Zivo Bioscience (ZIVO) just unveiled an announcement.
Zivo Bioscience, Inc. has implemented new incentive plans to motivate non-employee directors and align their interests with the company’s success. The 2024 Equity Incentive Plan allows for stock-based awards and sets annual compensation limits, while also introducing a replacement program for outdated stock options. Additionally, adjustments to the Non-Employee Director Compensation Policy now permit equity as restricted stock or units and increase annual cash fees. In a move to settle unpaid fees and foster commitment, stock has been granted in lieu of cash for services rendered. Furthermore, the company has amended its 2021 Equity Incentive Plan, increasing available shares for employee incentives and replacing old stock options with new grants to key officers, demonstrating the company’s proactive approach in using equity to attract and retain valuable leadership.
Learn more about ZIVO stock on TipRanks’ Stock Analysis page.
